Semaglutide is a glucagon-like peptide-1 agonist (GLP-1) that is prescribed to treat obesity. It is a once weekly injection. GLP-1 medications have been found to reduce hunger, increase satiety, and delay gastric emptying so that people feel full longer. GLP-1 medications have been found to be effective for long-term weight loss, making it an ideal treatment for many who struggle with weight. The FDA has approved it for people who meet the eligibility criteria. Semaglutide is the name of the active ingredient in the brands Ozempic® and Wegovy®.
Pharmaceutical products are only available to members of the Lifeforce Membership ($129/month) and are contingent on blood tests results and clinician video consult. To qualify for the program you must reside in an eligible state* and purchase a Lifeforce Diagnostic ($549).
*Eligible States: AK, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY